About MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
During the past decade, MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." #1 sponsor was "H. Lundbeck A/S" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Newron Pharmaceuticals SPA" with 2 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored and "Janssen Research & Development, LLC"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
Clinical Trials Conditions at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
According to Clinical.Site data, the most researched conditions in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." are
"Idiopathic Parkinson's Disease" (2 trials), "Migraine" (2 trials), "Dementia-related Psychosis" (1 trials), "Early Parkinson Disease" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
Most popular intervention types in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (2 trials), "Cenobamate" (1 trials), "Eptinezumab" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
The vast majority of trials in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o." are
10 trials for "All" genders.
Clinical Trials Status at MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.
Currently, there are NaN active trials in "MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 6 completed trials in MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".